{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:37:08Z","timestamp":1759963028044},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,6,15]],"date-time":"2012-06-15T00:00:00Z","timestamp":1339718400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s10875-012-9716-x","type":"journal-article","created":{"date-parts":[[2012,6,14]],"date-time":"2012-06-14T12:23:17Z","timestamp":1339676597000},"page":"1221-1232","source":"Crossref","is-referenced-by-count":26,"title":["Etanercept Downregulates the Th17 Pathway and Decreases the IL-17+\/IL-10+ Cell Ratio in Patients with Psoriasis Vulgaris"],"prefix":"10.1007","volume":"32","author":[{"given":"Emiliano","family":"Antiga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Volpi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Cardilicchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Fil\u00ec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Manuelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Parronchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzia","family":"Caproni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,15]]},"reference":[{"key":"9716_CR1","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","volume":"445","author":"MA Lowes","year":"2007","unstructured":"Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature. 2007;445:866\u201373.","journal-title":"Nature"},{"key":"9716_CR2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.it.2006.12.005","volume":"28","author":"O Boyman","year":"2007","unstructured":"Boyman O, Conrad C, Tonel G, Gilliet M, Nestle FO. The pathogenic role of tissue-resident immune cells in psoriasis. Trends Immunol. 2007;28:51\u20137.","journal-title":"Trends Immunol."},{"key":"9716_CR3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/1523-1747.ep12371752","volume":"102","author":"JF Schlaak","year":"1994","unstructured":"Schlaak JF, Buslau M, Jochum W, Hermann E, Girndt M, Gallati H, et al. T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol. 1994;102:145\u20139.","journal-title":"J Invest Dermatol."},{"key":"9716_CR4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.20030451","volume":"199","author":"E Lee","year":"2004","unstructured":"Lee E, Trepicchio WL, Oestreicher JL, Pittman D, Wang F, Chamian F, et al. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med. 2004;199:125\u201330.","journal-title":"J Exp Med."},{"key":"9716_CR5","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1084\/jem.20071094","volume":"204","author":"LC Zaba","year":"2007","unstructured":"Zaba LC, Cardinale I, Gilleaudeau P, Sullivan-Whalen M, Su\u00e1rez-Fari\u00f1as M, Fuentes-Duculan J, et al. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med. 2007;204:3183\u201394.","journal-title":"J Exp Med."},{"key":"9716_CR6","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature05505","volume":"445","author":"Y Zheng","year":"2007","unstructured":"Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 2007;445:648\u201351.","journal-title":"Nature"},{"key":"9716_CR7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jdermsci.2010.03.018","volume":"58","author":"YH Lo","year":"2010","unstructured":"Lo YH, Torii K, Saito C, Furuhashi T, Maeda A, Morita A. Serum IL-22 correlates with psoriatic severity and serum IL-6 correlates with susceptibility to phototherapy. J Dermatol Sci. 2010;58:225\u20137.","journal-title":"J Dermatol Sci."},{"key":"9716_CR8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/jid.2008.194","volume":"129","author":"LC Zaba","year":"2009","unstructured":"Zaba LC, Fuentes-Duculan J, Eungdamrong NJ, Abello MV, Novitskaya I, Pierson KC, et al. Psoriasis is characterized by accumulation of immunostimulatory and Th1\/Th17 cell-polarizing myeloid dendritic cells. J Invest Dermatol. 2009;129:79\u201388.","journal-title":"J Invest Dermatol."},{"key":"9716_CR9","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.4049\/jimmunol.1001538","volume":"185","author":"G Tonel","year":"2010","unstructured":"Tonel G, Conrad C, Laggner U, Di Meglio P, Grys K, McClanahan TK, et al. Cutting edge: A critical functional role for IL-23 in psoriasis. J Immunol. 2010;185:5688\u201391.","journal-title":"J Immunol."},{"key":"9716_CR10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/eji.200839050","volume":"39","author":"F Annunziato","year":"2009","unstructured":"Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S. Human Th17 cells: are they different from murine Th17 cells? Eur J Immunol. 2009;39:637\u201340.","journal-title":"Eur J Immunol."},{"key":"9716_CR11","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.micinf.2009.04.004","volume":"11","author":"F Sallusto","year":"2009","unstructured":"Sallusto F, Lanzavecchia A. Human Th17 cells in infection and autoimmunity. Microbes Infect. 2009;11:620\u20134.","journal-title":"Microbes Infect."},{"key":"9716_CR12","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/jid.2009.399","volume":"130","author":"S Kagami","year":"2010","unstructured":"Kagami S, Rizzo HL, Lee JJ, Koguchi Y, Blauvelt A. Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol. 2010;130:1373\u201383.","journal-title":"J Invest Dermatol."},{"key":"9716_CR13","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","volume":"128","author":"MA Lowes","year":"2008","unstructured":"Lowes MA, Kikuchi T, Fuentes-Duculan J, Cardinale I, Zaba LC, Haider AS, et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol. 2008;128:1207\u201311.","journal-title":"J Invest Dermatol."},{"key":"9716_CR14","first-page":"3573","volume":"119","author":"S Eyerich","year":"2009","unstructured":"Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, Pallotta S, et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest. 2009;119:3573\u201385.","journal-title":"J Clin Invest."},{"key":"9716_CR15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jdermsci.2008.04.015","volume":"51","author":"L Chen","year":"2008","unstructured":"Chen L, Shen Z, Wang G, Fan P, Liu Y. Dynamic frequency of CD4\u2009+\u2009CD25\u2009+\u2009Foxp3+ Treg cells in psoriasis vulgaris. J Dermatol Sci. 2008;51:200\u20133.","journal-title":"J Dermatol Sci."},{"key":"9716_CR16","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4049\/jimmunol.174.1.164","volume":"174","author":"H Sugiyama","year":"2005","unstructured":"Sugiyama H, Gyulai R, Toichi E, Garaczi E, Shimada S, Stevens SR, et al. Dysfunctional blood and target tissue CD4\u2009+\u2009CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol. 2005;174:164\u201373.","journal-title":"J Immunol."},{"key":"9716_CR17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0065-2776(10)05004-2","volume":"105","author":"K Fujio","year":"2010","unstructured":"Fujio K, Okamura T, Yamamoto K. The Family of IL-10-secreting CD4+ T cells. Adv Immunol. 2010;105:99\u2013130.","journal-title":"Adv Immunol."},{"key":"9716_CR18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.clim.2007.01.006","volume":"123","author":"BF Chong","year":"2007","unstructured":"Chong BF, Wong HK. Immunobiologics in the treatment of psoriasis. Clin Immunol. 2007;123:129\u201338.","journal-title":"Clin Immunol."},{"key":"9716_CR19","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1177\/039463201002300310","volume":"23","author":"E Antiga","year":"2010","unstructured":"Antiga E, Volpi W, Chiarini C, Cardilicchia E, Fil\u00ec L, Manuelli C, et al. The role of etanercept on the expression of markers of T helper 17 cells and their precursors in skin lesions of patients with psoriasis vulgaris. Int J Immunopathol Pharmacol. 2010;23:767\u201374.","journal-title":"Int J Immunopathol Pharmacol."},{"key":"9716_CR20","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1084\/jem.20070663","volume":"204","author":"F Annunziato","year":"2007","unstructured":"Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B, et al. Phenotypic and functional features of human Th17 cells. J Exp Med. 2007;204:1849\u201361.","journal-title":"J Exp Med."},{"key":"9716_CR21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s10875-008-9233-0","volume":"29","author":"M Caproni","year":"2009","unstructured":"Caproni M, Antiga E, Melani L, Volpi W, Del Bianco E, Fabbri P. Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial. J Clin Immunol. 2009;29:210\u20134.","journal-title":"J Clin Immunol."},{"key":"9716_CR22","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","volume":"296","author":"JM Gelfand","year":"2006","unstructured":"Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296:1735\u201341.","journal-title":"JAMA"},{"key":"9716_CR23","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jaci.2010.12.009","volume":"127","author":"A H\u00e4nsel","year":"2011","unstructured":"H\u00e4nsel A, G\u00fcnther C, Ingwersen J, Starke J, Schmitz M, Bachmann M, et al. Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17\/TH1 T-cell responses. J Allergy Clin Immunol. 2011;127:787\u201394.e1-9.","journal-title":"J Allergy Clin Immunol."},{"key":"9716_CR24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.clim.2009.11.008","volume":"135","author":"L Zhang","year":"2010","unstructured":"Zhang L, Yang XQ, Cheng J, Hui RS, Gao TW. Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity. Clin Immunol. 2010;135:108\u201317.","journal-title":"Clin Immunol."},{"key":"9716_CR25","doi-asserted-by":"crossref","first-page":"e14108","DOI":"10.1371\/journal.pone.0014108","volume":"5","author":"PC Res","year":"2010","unstructured":"Res PC, Piskin G, de Boer OJ, van der Loos CM, Teeling P, Bos JD, et al. Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis. PLoS One. 2010;5:e14108.","journal-title":"PLoS One"},{"key":"9716_CR26","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.4049\/jimmunol.181.7.4733","volume":"181","author":"I Kryczek","year":"2008","unstructured":"Kryczek I, Bruce AT, Gudjonsson JE, Johnston A, Aphale A, Vatan L, et al. Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol. 2008;181:4733\u201341.","journal-title":"J Immunol."},{"key":"9716_CR27","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000238305","volume":"219","author":"P Quaglino","year":"2009","unstructured":"Quaglino P, Ortoncelli M, Comessatti A, Ponti R, Novelli M, Bergallo M, et al. Circulating CD4+CD25 bright FOXP3+ T cells are up-regulated by biological therapies and correlate with the clinical response in psoriasis patients. Dermatology. 2009;219:250\u20138.","journal-title":"Dermatology"},{"key":"9716_CR28","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2133.2010.09650.x","volume":"162","author":"L Diluvio","year":"2010","unstructured":"Diluvio L, Romiti ML, Angelini F, Campione E, Rossi P, Prinz JC, et al. Infliximab therapy induces increased polyclonality of CD4\u2009+\u2009CD25+ regulatory T cells in psoriasis. Br J Dermatol. 2010;162:895\u20137.","journal-title":"Br J Dermatol."},{"key":"9716_CR29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.5021\/ad.2010.22.4.397","volume":"22","author":"WJ Yun","year":"2010","unstructured":"Yun WJ, Lee DW, Chang SE, Yoon GS, Huh JR, Won CH, et al. Role of CD4CD25FOXP3 regulatory T cells in psoriasis. Ann Dermatol. 2010;22:397\u2013403.","journal-title":"Ann Dermatol."},{"key":"9716_CR30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000330330","volume":"223","author":"P Quaglino","year":"2011","unstructured":"Quaglino P, Bergallo M, Ponti R, Barberio E, Cicchelli S, Buffa E, et al. Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response. Dermatology. 2011;223:57\u201367.","journal-title":"Dermatology"},{"key":"9716_CR31","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jaci.2009.08.046","volume":"124","author":"LC Zaba","year":"2009","unstructured":"Zaba LC, Su\u00e1rez-Fari\u00f1as M, Fuentes-Duculan J, Nograles KE, Guttman-Yassky E, Cardinale I, et al. Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes. J Allergy Clin Immunol. 2009;124:1022\u201310.e1-395.","journal-title":"J Allergy Clin Immunol."},{"key":"9716_CR32","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1146\/annurev.immunol.25.022106.141557","volume":"25","author":"CT Weaver","year":"2007","unstructured":"Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell linear. Annu Rev Immunol. 2007;25:821\u201352.","journal-title":"Annu Rev Immunol."},{"key":"9716_CR33","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1084\/jem.20060285","volume":"203","author":"C Sutton","year":"2006","unstructured":"Sutton C, Brereton C, Keogh B, Mills KH, Lavelle EC. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med. 2006;203:1685\u201391.","journal-title":"J Exp Med."},{"key":"9716_CR34","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.4049\/jimmunol.1003372","volume":"186","author":"J Biton","year":"2011","unstructured":"Biton J, Semerano L, Delavall\u00e9e L, Lemeiter D, Laborie M, Grouard-Vogel G, et al. Interplay between TNF and regulatory T cells in a TNF-driven murine model of arthritis. J Immunol. 2011;186:3899\u2013910.","journal-title":"J Immunol."},{"key":"9716_CR35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.20040165","volume":"200","author":"MR Ehrenstein","year":"2004","unstructured":"Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFa therapy. J Exp Med. 2004;200:277\u201385.","journal-title":"J Exp Med."},{"key":"9716_CR36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1084\/jem.20061531","volume":"204","author":"S Nadkarni","year":"2007","unstructured":"Nadkarni S, Mauri C, Ehrenstein MR. Anti-TNF-a therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-b. J Exp Med. 2007;204:33\u20139.","journal-title":"J Exp Med."},{"key":"9716_CR37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0923-1811(00)00167-5","volume":"26","author":"H Duan","year":"2001","unstructured":"Duan H, Koga T, Kohda F, Hara H, Urabe K, Furue M. Interleukin-8-positive neutrophils in psoriasis. J Dermatol Sci. 2001;26:119\u201324.","journal-title":"J Dermatol Sci."},{"key":"9716_CR38","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1365-2133.2010.09992.x","volume":"163","author":"S Coimbra","year":"2010","unstructured":"Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, et al. Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-\u03b1 levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy. Br J Dermatol. 2010;163:1282\u201390.","journal-title":"Br J Dermatol."},{"key":"9716_CR39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cca.2008.04.005","volume":"394","author":"AT Pietrzak","year":"2008","unstructured":"Pietrzak AT, Zalewska A, Chodorowska G, Krasowska D, Michalak-Stoma A, Nockowski P, et al. Cytokines and anticytokines in psoriasis. Clin Chim Acta. 2008;394:7\u201321.","journal-title":"Clin Chim Acta"},{"key":"9716_CR40","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1096\/fasebj.10.9.8801161","volume":"10","author":"GJ Fisher","year":"1996","unstructured":"Fisher GJ, Voorhees JJ. Molecular mechanisms of retinoid actions in skin. FASEB J. 1996;10:1002\u201313.","journal-title":"FASEB J."}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-012-9716-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-012-9716-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-012-9716-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T00:20:44Z","timestamp":1561854044000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-012-9716-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,15]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["9716"],"URL":"https:\/\/doi.org\/10.1007\/s10875-012-9716-x","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,15]]}}}